{"id":"W4324136789","doi":"10.1200/jco.2023.41.6_suppl.18","title":"Rucaparib for metastatic castration-resistant prostate cancer (mCRPC): TRITON3 interim overall survival and efficacy of rucaparib vs docetaxel or second-generation androgen pathway inhibitor therapy.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; CancerCare Manitoba; Ottawa Hospital","funders":"","keywords":"Medicine; Clinical endpoint; Prostate cancer; Enzalutamide; Oncology; Internal medicine; Docetaxel; Population; Progression-free survival; Interim analysis; Cancer; Randomized controlled trial; Chemotherapy; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001742906,0.0007166048,0.001347296,0.0004453229,0.000215222,0.0006761847,0.0005380661,0.0006981425,0.00503743],"category_scores_gemma":[0.001196206,0.0002848423,0.001582173,0.0004554388,0.0004360171,0.0006133327,0.0003802962,0.001594465,0.0005938202],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009418757,"about_ca_system_score_gemma":0.001180916,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008505188,"about_ca_topic_score_gemma":0.002439816,"domain_scores_codex":[0.9994361,0.0002690337,0.00004646439,0.00007737151,0.00007595132,0.0000951352],"domain_scores_gemma":[0.9991341,0.0002213091,0.0002662866,0.00006506724,0.00004394737,0.0002692013],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9407033,0.006262118,0.005777338,0.0003097015,0.0009721999,0.00004842385,0.00005426209,0.001010891,0.004855053,0.0001094488,0.001374859,0.03852248],"study_design_scores_gemma":[0.4026129,0.52775,0.05360196,0.00007591383,0.002741573,0.0002936061,0.00006717574,0.002141025,0.006198321,0.0003308591,0.004138364,0.00004837236],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921407,0.001923208,0.0003430511,0.0001951537,0.00007072921,0.0007521124,0.002366551,0.0000558235,0.002152706],"genre_scores_gemma":[0.9918492,0.0006819483,0.0005583841,0.0002169074,0.00008699061,0.0007846332,0.003954651,0.0000210651,0.001846316],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00503743,"threshold_uncertainty_score":0.01685184,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2779043447976356,"score_gpt":0.4950200663775198,"score_spread":0.2171157215798842,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}